Medicare Enrolled

Dr. Devprakash Samuel, MD

Neurology · Fort Gratiot, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3050 KRAFFT RD, Fort Gratiot, MI 48059
8103857700
In practice since 2006 (19 years)
NPI: 1760579171 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Samuel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Samuel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Samuel

Dr. Devprakash Samuel is a neurology specialist in Fort Gratiot, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Samuel performed 484 Medicare services across 291 unique beneficiaries.

Between the years covered by Open Payments, Dr. Samuel received a total of $5,995 from 46 pharmaceutical and/or device companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Samuel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 31% volume in MI $5,995 industry payments

Medicare Practice Summary

Medicare Utilization ↗
484
Medicare services
Top 31% in MI for neurology
291
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
324 $88 $140
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
51 $280 $606
New patient office visit, complex (60-74 min) 38 $163 $300
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
38 $139 $200
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
33 $65 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,995
Total received (2018-2024)
Avg $856/year across 7 years
Top 29% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
278
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,756 (96.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$239 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,431
2023
$1,123
2022
$1,340
2021
$1,070
2020
$73
2019
$646
2018
$311

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$413
EMD Serono, Inc.
$329
Biogen, Inc.
$159
Neurelis, Inc.
$101
ABBVIE INC.
$73
Novartis Pharmaceuticals Corporation
$51
Alexion Pharmaceuticals, Inc.
$48
Celgene Corporation
$34
PFIZER INC.
$29
Lilly USA, LLC
$24
Sumitomo Pharma America, Inc.
$23
CATALYST PHARMACEUTICALS, INC.
$23
Kyowa Kirin, Inc.
$21
Vanda Pharmaceuticals Inc.
$21
Cycle Pharmaceuticals Inc
$20
JAZZ PHARMACEUTICALS INC.
$19
Teva Pharmaceuticals USA, Inc.
$16
Eisai Inc.
$14
Aucta Pharmaceuticals, Inc.
$12
Top 3 companies account for 63.0% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,311
EMD Serono, Inc.
$765
Neurelis, Inc.
$385
Biogen, Inc.
$377
Teva Pharmaceuticals USA, Inc.
$329
Celgene Corporation
$286
E.R. Squibb & Sons, L.L.C.
$232
GENZYME CORPORATION
$214
Alexion Pharmaceuticals, Inc.
$187
Janssen Pharmaceuticals, Inc
$185
Eisai Inc.
$140
ABBVIE INC.
$134
Lilly USA, LLC
$119
Novartis Pharmaceuticals Corporation
$115
Sunovion Pharmaceuticals Inc.
$107
EISAI INC.
$99
Sumitomo Pharma America, Inc.
$82
SK Life Science, Inc.
$75
Novo Nordisk Inc
$63
Adamas Pharmaceuticals, Inc.
$63
Acorda Therapeutics, Inc
$62
Kyowa Kirin, Inc.
$56
Neurocrine Biosciences, Inc.
$47
TG THERAPEUTICS, INC.
$43
Amgen Inc.
$41
Medtronic Vascular, Inc.
$40
Genentech USA, Inc.
$39
Otsuka America Pharmaceutical, Inc.
$30
PFIZER INC.
$29
ACADIA Pharmaceuticals Inc
$29
Bayer HealthCare Pharmaceuticals Inc.
$27
Allergan, Inc.
$26
Mallinckrodt Hospital Products Inc.
$24
Catalyst Pharmaceuticals, Inc.
$24
CATALYST PHARMACEUTICALS, INC.
$23
Vanda Pharmaceuticals Inc.
$21
OWP Pharmaceuticals, Inc.
$20
Cycle Pharmaceuticals Inc
$20
Biohaven Pharmaceutical Holding Company Ltd.
$20
JAZZ PHARMACEUTICALS INC.
$19
ARGENX US, INC.
$16
Allergan Inc.
$15
Amneal Pharmaceuticals LLC
$15
GE Healthcare
$14
Avanir Pharmaceuticals, Inc.
$14
Aucta Pharmaceuticals, Inc.
$12
Top 3 companies account for 41.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BRIUMVI · Betaseron · Briviact · EMGALITY · EPIDIOLEX · FYCOMPA · Fintepla · Fycompa · GOCOVRI · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · Leqembi · MAVENCLAD · Mavenclad · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · Ocrevus · Ozempic · PONVORY · Ponvory · QULIPTA · RYTARY · Rebif · Reveal LINQ · SOLIRIS · SUBVENITE · TECFIDERA · TYSABRI · Tascenso ODT · UBRELVY · ULTOMIRIS · VALTOCO · VUMERITY · VYVGART · Vimpat · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Fort Gratiot?
Compare neurologists in the Fort Gratiot area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
7
Per 100K population
4.4
County median income
$69,349
Nearest hospital
LAKE HURON MEDICAL CENTER
7.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Samuel is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Samuel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Samuel performed 324 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Samuel receive payments from pharmaceutical companies?
Yes. Dr. Samuel received a total of $5,995 from 46 companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Samuel's costs compare to other neurologists in Fort Gratiot?
Dr. Samuel's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Samuel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →